Viewing Study NCT00073450


Ignite Creation Date: 2025-12-24 @ 4:46 PM
Ignite Modification Date: 2025-12-25 @ 2:45 PM
Study NCT ID: NCT00073450
Status: TERMINATED
Last Update Posted: 2015-04-21
First Post: 2003-11-20
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck (Study P02530)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module References Module